Related references
Note: Only part of the references are listed.Nekrotisierende Hepatitis nach Einnahme pflanzlicher Heilmittel
S. Strahl et al.
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT (2008)
Effects of kava alkaloid, pipermethystine, and kavalactones on oxidative stress and cytochrome P450 in F-344 rats
Steven T. S. Lim et al.
TOXICOLOGICAL SCIENCES (2007)
Effect of goldenseal (Hydrastis canadensis) and kava kava (Piper methysticum) supplementation on digoxin pharmacokinetics in humans
Bill J. Gurley et al.
DRUG METABOLISM AND DISPOSITION (2007)
Immunohistochemical analysis of expressions of hepatic cytochrome P450 in F344 rats following oral treatment with kava extract
Natasha P. Clayton et al.
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY (2007)
Potential medicinal plants for CNS disorders: an overview
Vikas Kumar
PHYTOTHERAPY RESEARCH (2006)
Herb-drug interactions in oncology: Focus on mechanisms of induction
Irma Meijerman et al.
ONCOLOGIST (2006)
In vitro cytotoxicity of nonpolar constituents from different parts of kava plant (Piper methysticum)
JW Jhoo et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2006)
Inhibition of TNFα-induced activation of nuclear factor κB by kava (Piper methysticum) derivatives
F Folmer et al.
BIOCHEMICAL PHARMACOLOGY (2006)
Kavalactones fail to inhibit alcohol dehydrogenase in vitro
J Anke et al.
PHYTOMEDICINE (2006)
Herbal remedies for anxiety - a systematic review of controlled clinical trials
E Ernst
PHYTOMEDICINE (2006)
Pharmacokinetics and disposition of the kavalactone kawain: Interaction with kava extract and kavalactones in vivo and in vitro
JM Mathews et al.
DRUG METABOLISM AND DISPOSITION (2005)
Potential for interaction of kava and St. John's wort with drugs
YN Singh
JOURNAL OF ETHNOPHARMACOLOGY (2005)
Altered expression of cytochrorne P450 and possible correlation with preneoplastic changes in early stage of rat hepatocarcinogenesis
LL Liu et al.
ACTA PHARMACOLOGICA SINICA (2005)
Traditional aqueous kava extracts inhibit cytochrome P450 1A2 in humans: Protective effect against environmental carcinogens?
S Russmann et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Synthesis, in vitro reactivity, and identification of 6-phenyl-3-hexen-2-one in human urine after Kava-Kava (Piper methysticum) ingestion
LH Zou et al.
PLANTA MEDICA (2005)
Molecular mechanisms of toxicity of important food-borne phytotoxins
IMCM Rietjens et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2005)
Herb-drug interactions - A literature review
ZP Hu et al.
DRUGS (2005)
Kava kava: examining new reports of toxicity
DL Clouatre
TOXICOLOGY LETTERS (2004)
Kava hepatotoxicity: Are we any closer to the truth?
J Anke et al.
PLANTA MEDICA (2004)
Composition and biological activity of traditional and commercial kava extracts
CS Côté et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Pharmacokinetic and pharmacodynamic drug interactions with Kava (Piper methysticum Forst. f.)
J Anke et al.
JOURNAL OF ETHNOPHARMACOLOGY (2004)
In vitro toxicity of kava alkaloid, pipermethystine, in HepG2 cells compared to kavalactones
PV Nerurkar et al.
TOXICOLOGICAL SCIENCES (2004)
Kava lactones and the kava-kava controversy
PA Whitton et al.
PHYTOCHEMISTRY (2003)
Hepatic injury due to traditional aqueous extracts of kava root in New Caledonia
S Russmann et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2003)
Hepatitis induced by Kava (Piper methysticum rhizoma)
F Stickel et al.
JOURNAL OF HEPATOLOGY (2003)
Identification of novel electrophilic metabolites of Piper methysticum Forst. (Kava)
BM Johnson et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2003)
Regulation of CYP3A4 expression in human hepatocytes by pharmaceuticals and natural products
JL Raucy
DRUG METABOLISM AND DISPOSITION (2003)
Piperidine alkaloids from Piper methysticum
K Dragull et al.
PHYTOCHEMISTRY (2003)
Toxicity of kava pyrones, drug safety and precautions - a case study
J Schulze et al.
PHYTOMEDICINE (2003)
Acute hepatitis induced by kava kava
CL Humberston et al.
JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY (2003)
Liver function test abnormalities in users of aqueous kava extracts
AR Clough et al.
JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY (2003)
Inhibition of cytochrome P450 3A4 by extracts and kavalactones of Piper methysticum (Kava-Kava)
M Unger et al.
PLANTA MEDICA (2002)
Inhibition of human cytochrome P450 activities by kava extract and kavalactones
JM Mathews et al.
DRUG METABOLISM AND DISPOSITION (2002)
Safety concerns about kava not unique
PAGM De Smet
LANCET (2002)
Effects of herbal components on cDNA-expressed cytochrome P450 enzyme catalytic activity
L Zou et al.
LIFE SCIENCES (2002)
Kava-induced fulminant hepatic failure
JV Campo et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2002)
Kava-kava and anxiety: Growing knowledge about the efficacy and safety
AR Bilia et al.
LIFE SCIENCES (2002)
Receptor-dependent transcriptional activation of cytochrome P4503A genes: induction mechanisms, species differences and interindividual variation in man
GG Gibson et al.
XENOBIOTICA (2002)
Cyclooxygenase enzyme inhibitory compounds with antioxidant activities from Piper methysticum (kava kava) roots
D Wu et al.
PHYTOMEDICINE (2002)
A protective role for cyclooxygenase-2 in drug-induced liver injury in mice
TP Reilly et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2001)
Fulminant liver failure after administration of the herbal antidepressant Kava-Kava
M Kraft et al.
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT (2001)
Kava hepatotoxicity
S Russmann et al.
ANNALS OF INTERNAL MEDICINE (2001)
Anxiolytic effects of kava extract and kavalactones in the chick social separation-stress paradigm
KK Smith et al.
PSYCHOPHARMACOLOGY (2001)
Hepatitis associated with Kava, a herbal remedy for anxiety
M Escher et al.
BRITISH MEDICAL JOURNAL (2001)
Share Paper
